- Scheme Category:
- Other Scheme >
- Index Funds
NAV: ₹ ↓ -0.03%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth and its peers as on 7 July, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth | 13.01% | -0.03% | 2.14% | 7.16% | 17.05% | 19.42% | 21.61% | 13.7% | - | - |
| SBI NIFTY INDEX FUND - DIRECT PLAN - GROWTH | -8.18% | -2.12% | -0.48% | 3.59% | 0% | -5.61% | 8.31% | 9.71% | 11.82% | 12.03% |
| SBI Nifty Next 50 Index Fund - Direct Plan - Growth | 2.06% | -1.85% | -1.66% | 2.84% | 7.29% | 3.83% | 17.74% | 13.32% | - | - |
| SBI CPSE Bond Plus SDL Sep 2026 50:50 Index Fund - Direct Plan - Growth | 3.08% | 0.02% | 0.09% | 0.54% | 1.51% | 5.9% | 7.25% | - | - | - |
| SBI CRISIL IBX Gilt Index - April 2029 Fund - Direct Plan - Growth | 2.52% | -0.11% | 0.06% | 0.78% | 1.73% | 5.22% | 7.79% | - | - | - |
| SBI |CRISIL IBX Gilt Index - June 2036 Fund - Direct Plan - Growth | 3.33% | -0.21% | 0.35% | 2.11% | 3.09% | 4.64% | 8.09% | - | - | - |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | 16.96% | -3.92% | 27.42% | 27.77% | 5.49% |
Discrete returns (monthly)
| Month | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -0.2% | 1.42% | 3.83% | -0.71% | -2.51% | 5.16% | -4.55% | 2.98% | 2.43% | 7.08% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.50% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.50% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.73% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.59% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 5.30% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 5.08% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.84% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.76% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.13% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.55% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.77% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.44% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.37% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.27% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.79% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.72% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.55% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.53% |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 1.23% |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 1.19% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 1.05% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 0.89% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 0.87% |
| Narayana Hrudayalaya ltd. | NH (INE410P01011) | Healthcare Services | 0.82% |
| GlaxoSmithKline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.70% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 0.55% |
| Emcure Pharmaceuticals Ltd. | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 0.31% |
| ELI LILLY & CO | (US5324571083) | Pharmaceuticals | 5.72% |
| JOHNSON & JOHNSON | (US4781601046) | Pharmaceuticals | 4.52% |
| ABBVIE INC | (US00287Y1091) | Biotechnology | 2.95% |
| MERCK & CO.INC | (US58933Y1055) | Pharmaceuticals | 2.29% |
| NOVARTIS AG | (US66987V1098) | Pharmaceuticals | 2.23% |
| AMGEN INC | (US0311621009) | Biotechnology | 1.45% |
| THERMO FISHER SCIENTIFIC INC | (US8835561023) | Life Sciences Tools & Services | 1.41% |
| ABBOTT LABORATORIES | (US0028241000) | Health Care Equipment & Supplies | 1.36% |
| GILEAD SCIENCES INC | (US3755581036) | Biotechnology | 1.33% |
| INTUITIVE SURGICAL INC | (US46120E6023) | Health Care Equipment & Supplies | 1.26% |
| DANAHER CORP | (US2358511028) | Health Care Equipment & Supplies | 0.93% |
| Novo Nordisk A/S | (US6701002056) | Pharmaceuticals & Biotechnology | 0.91% |
| STRYKER CORP | (US8636671013) | Health Care Equipment & Supplies | 0.87% |
| VERTEX PHARMACEUTICALS INC | (US92532F1003) | Biotechnology | 0.87% |
| MEDTRONIC PLC | (IE00BTN1Y115) | Health Care Equipment & Supplies | 0.85% |
| Regeneron Pharmaceuticals Inc | (US75886F1075) | Pharmaceuticals | 0.63% |
| BECTON DICKINSON AND CO | (US0758871091) | Health Care Equipment & Supplies | 0.34% |
| AGILENT TECHNOLOGIES INC | (US00846U1016) | Life Sciences Tools & Services | 0.25% |
| IQVIA HOLDINGS INC | (US46266C1053) | Life Sciences Tools & Services | 0.21% |
| WATERS CORP | (US9418481035) | Pharmaceuticals | 0.09% |
Portfolio data is as on date 31 March, 2026
NAV history
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 7 July, 2026 | 24.2207 | -0.03% |
| 6 July, 2026 | 24.228 | 0.93% |
| 2 July, 2026 | 24.0055 | 1.58% |
| 1 July, 2026 | 23.6332 | -0.34% |
| 30 June, 2026 | 23.7138 | -0.14% |
| 29 June, 2026 | 23.7461 | 1.91% |
| 25 June, 2026 | 23.3019 | 0.45% |
| 24 June, 2026 | 23.1985 | 0.47% |
| 23 June, 2026 | 23.0901 | 0.97% |
| 22 June, 2026 | 22.8688 | 1.74% |
| 18 June, 2026 | 22.4769 | 0.38% |
| 17 June, 2026 | 22.3921 | -0.56% |
| 16 June, 2026 | 22.5186 | -0.2% |
| 15 June, 2026 | 22.5646 | -0.91% |
| 12 June, 2026 | 22.7716 | -0.08% |
| 11 June, 2026 | 22.7893 | 0.81% |
| 10 June, 2026 | 22.6054 | -0.7% |
| 9 June, 2026 | 22.7657 | 0.82% |
| 8 June, 2026 | 22.5812 | -0.09% |
| 5 June, 2026 | 22.6023 | 0.56% |
| 4 June, 2026 | 22.4765 | 1.2% |
| 3 June, 2026 | 22.211 | 0.8% |
| 2 June, 2026 | 22.0356 | -0.5% |
| 1 June, 2026 | 22.1462 | -1.23% |
| 29 May, 2026 | 22.4214 | -1.18% |
| 27 May, 2026 | 22.6887 | 0.31% |
| 26 May, 2026 | 22.6197 | -0.48% |
| 22 May, 2026 | 22.729 | -0.81% |
| 21 May, 2026 | 22.9145 | 0.39% |
| 20 May, 2026 | 22.8261 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The latest NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is 24.2207 as on 7 July, 2026.What are YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 13.01% as on 7 July, 2026.What are 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 19.42% as on 7 July, 2026.What are 3 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 3 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 21.61% as on 7 July, 2026.What are 5 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 5 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 13.7% as on 7 July, 2026.